Jump to main content

yr 〜
yr

Search results 7

Trends in patented drug prices (PMPRB study series ; S-9811)

Trends in patented drug prices (PMPRB study series ; S-9811)
Paper図書
Ronald J. Corvari.Patented Medicine Prices Review Board1998.<Y629-99-49>
National Diet Library
  • Subject HeadingDrugs--Prices--Canada. Pharmacy--Canada--Statistics....

International prescription drug parity : are Americans being protected or gouged? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, April 3, 2003 Serial no. 108-12 (United States. Congress. House. Committee on Government Reform)

International prescription drug parity : are Americans being protected or gouged? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, April 3, 2003 Serial no. 108-12 (United States. Congress. House. Committee on Government Reform)
Microform図書
2003<YCA-Y 4.G 74/7:P 92/20>
National Diet Library

Road map for the next decade : report on the PMPRB's public consultations.

Road map for the next decade : report on the PMPRB's public consultations.
Paper図書
Patented Medicine Prices Review Board1998.<Y629-99-48>
National Diet Library
  • Subject HeadingDrugs--Prices--Canada. Prescription pricing--Canada....

Prescription drugs [microform] : companies typically charge more in the United States than in Canada : statement of Janet L. Shikles, Director, Health Financing and Policy Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office (Testimony ; GAO/T-HRD-93-5)

Prescription drugs [microform] : companies typically charge more in the United States than in Canada : statement of Janet L. Shikles, Director, Health Financing and Policy Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office (Testimony ; GAO/T-HRD-93-5)
Microform図書
1993<YCA-GA 1.5/2:T-HRD-93-5>
National Diet Library

Prescription drug prices microform : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate / United States General Accounting Office

Prescription drug prices microform : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate / United States General Accounting Office
Microform図書
1993<YCA-GA 1.13:HRD-93-51>
National Diet Library

Compulsory patent licensing of drugs in Canada : have the full price benefits been realized? (Background study)

Compulsory patent licensing of drugs in Canada : have the full price benefits been realized? (Background study)
Paper図書
Paul K. Gorecki.Commission of Inquiry on the Pharmaceutical Industry1985.<Y629-87-42>
National Diet Library
  • Subject HeadingDrugs--Prices--Canada. Drugs--Canada--Patents. Drugs...

Transfer pricing of drugs and pharmaceutical intermediate products (Background study)

Transfer pricing of drugs and pharmaceutical intermediate products (Background study)
Paper図書
G. David Quirin.Commission of Inquiry on the Pharmaceutical Industry1985.<Y629-87-37>
National Diet Library
  • Subject Heading...ustry--Canada. Drugs--Prices--Canada. Industrie pharmaceutique--Can...

Reached to the end of result.

RSS